A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival

Acta Oncologica

Volumn 53, Issue 5, 2014, Pages 669-679

  Kinch, Amelie ^a   Baecklund, Eva ^a   Backlin, Carin ^a   Ekman, Tor ^b   Molin, Daniel ^a   Tufveson, Gunnar ^a   Fernberg, Pia ^b   Sundström, Christer ^a   Pauksens, Karlis ^a   Enblad, Gunilla ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ANTIBODY; TACROLIMUS;

ADULT; ARTICLE; CANCER INCIDENCE; CHILD; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART TRANSPLANTATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LARGE CELL LYMPHOMA; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; ORGAN TRANSPLANTATION; OVERALL SURVIVAL; PANCREAS TRANSPLANTATION; PHENOTYPE; POPULATION RESEARCH; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; PROGNOSIS; T CELL LYMPHOMA; ADOLESCENT; AGED; COMPLICATION; EPSTEIN BARR VIRUS INFECTION; INCIDENCE; INFANT; LYMPHOMA; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; YOUNG ADULT; AGE; B CELL LYMPHOMA; BONE MARROW; CLINICAL FEATURE; DISEASE ASSOCIATION; FEVER; GRAFT FAILURE; HODGKIN DISEASE; LYMPHOPROLIFERATIVE DISEASE; SURVIVAL; T LYMPHOCYTE; TONSILLITIS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HEPATITIS C; HUMANS; INCIDENCE; INFANT; LYMPHOMA; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; YOUNG ADULT;

EID: 84910681844     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2013.844853     Document Type: Article

References (29)

1. Opelz G, Dohler B. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant 2004; 4: 222-30.
2. Engels EA, Pfeiffer RM, Fraumeni JF, Jr., Kasiske BL, Israni AK, Snyder JJ, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011; 306: 1891-901.
3. Clarke CA, Morton LM, Lynch C, Pfeiffer RM, Hall EC, Gibson TM, et al. Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer 2013; 109: 280-8.
4. Quinlan SC, Pfeiffer RM, Morton LM, Engels EA. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Am J Hematol 2011; 86: 206-9.
5. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumors of haemotopoietic and lymphoid tissue, 4 ed. Lyon: IARC; 2008.
6. Caillard S, Lamy FX, Quelen C, Dantal J, Lebranchu Y, Lang P, et al. Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: Report of the French registry and analysis of subgroups of lymphomas. Am J Transplant 2012; 12: 682-93.
7. Nelson BP, Nalesnik MA, Bahler DW, Locker J, Fung JJ, Swerdlow SH. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: A distinct entity? Am J Surg Pathol 2000; 24: 375-85.
8. Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation 2005; 80: 1233-43.
9. Johnson LR, Nalesnik MA, Swerdlow SH. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: A histogenetic study. Am J Surg Pathol 2006; 30: 1604-12.
10. Capello D, Cerri M, Muti G, Berra E, Oreste P, Deambrogi C, et al. Molecular histogenesis of posttransplantation lymphoproliferative disorders. Blood 2003; 102: 3775-85.
11. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275-82.
12. Fernberg P, Edgren G, Adami J, Ingvar A, Bellocco R, Tufveson G, et al. Time trends in risk and risk determinants of non-Hodgkin lymphoma in solid organ transplant recipients. Am J Transplant 2011; 11: 2472-82.
13. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011; 11: 450.
14. Evens AM, David KA, Helenowski I, Nelson B, Kaufman D, Kircher SM, et al. Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: Outcomes and prognostic factors in the modern era. J Clin Oncol 2010; 28: 1038-46.
15. Ghobrial IM, Habermann TM, Maurer MJ, Geyer SM, Ristow KM, Larson TS, et al. Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders. J Clin Oncol 2005; 23: 7574-82.
16. Dierickx D, Tousseyn T, Sagaert X, Fieuws S, Wlodarska I, Morscio J, et al. Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: Incidence, clinicopathological characteristics and prognostic factors. Leuk Lymphoma Epub 2013 Apr 9.
17. Caillard S, Porcher R, Provot F, Dantal J, Choquet S, Durrbach A, et al. Post-transplantation lymphoproliferative disorder after kidney transplantation: Report of a nationwide French registry and the development of a new prognostic score. J Clin Oncol 2013; 31: 1302-9.
18. Parker A, Bowles K, Bradley JA, Emery V, Featherstone C, Gupte G, et al. Diagnosis of post-transplant lympho-prolifera tive disorder in solid organ transplant recipients-BCSH and BTS Guidelines. Br J Haematol 2010; 149: 675-92.
19. Morscio J, Dierickx D, Ferreiro JF, Herreman A, Van Loo P, Bittoun E, et al. Gene expression profiling reveals clear differences between EBV-positive and EBV-negative post-transplant lymphoproliferative disorders. Am J Transplant 2013; 13: 1305-16.
20. Aucejo F, Rofaiel G, Miller C. Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after liver transplantation? J Hepatol 2006; 44: 19-23.
21. Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S. Hepatitis C-Associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. J Hepatol 2013; 59: 169-77.
22. Choquet S, Oertel S, LeBlond V, Riess H, Varoqueaux N, Dorken B, et al. Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: Proceed with caution. Ann Hematol 2007; 86: 599-607.
23. Tsai DE, Hardy CL, Tomaszewski JE, Kotloff RM, Oltoff KM, Somer BG, et al. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: Analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation 2001; 71: 1076-88.
24. Leblond V, Dhedin N, Mamzer Bruneel MF, Choquet S, Hermine O, Porcher R, et al. Identification of prognostic factors in 61 patients with posttransplantation lympho-proliferative disorders. J Clin Oncol 2001; 19: 772-8.
25. Trappe R, Oertel S, Leblond V, Mollee P, Sender M, Reinke P, et al. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): The prospective international multicentre phase 2 PTLD-1 trial. Lancet Oncol 2012; 13: 196-206.
26. Caillard S, Lelong C, Pessione F, Moulin B. Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: Report of 230 cases from the French Registry. Am J Transplant 2006; 6: 2735-42.
27. Reshef R, Vardhanabhuti S, Luskin MR, Heitjan DF, Hadjiliadis D, Goral S, et al. Reduction of immuno-suppression as initial therapy for posttransplantation lymphoproliferative disorder (bigstar). Am J Transplant 2011; 11: 336-47.
28. Lucioni M, Capello D, Riboni R, Ippoliti G, Campana C, Bandiera L, et al. B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: Clinical and molecular-histogenetic study of 17 cases from a single institution. Transplantation 2006; 82: 1013-23.
29. Vakiani E, Basso K, Klein U, Mansukhani MM, Narayan G, Smith PM, et al. Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. Hematol Oncol 2008; 26: 199-211.